Citalopram
Indication
Depressive illness, panic disorder
MHRA Drug Safety Update - Citalopram and escitalopram: QT interval prolongation
Green
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Recommendation
LSCMMG Recommendation:
Green
Reason for decision:
Suitable for initiation in primary care
Supporting documents: